Table 4 Changes in benzodiazepine dispensing to children and youth following the April 2019 modification of the OHIP+ pharmacare program restricting coverage only to individuals without private insurance
Stratification | Rate of benzodiazepine dispensing (individuals per 100,000) March 2019 | Rate of benzodiazepine dispensing (individuals per 100,000 March 2020 | Relative percent change, March 2019 to March 2020 (95% confidence interval | ARIMA Model | April 2019 Ramp Intervention Estimate (95% confidence interval) |
|---|---|---|---|---|---|
Overall | 241.5 | 231.9 | -4.0% (-6.7% to -1.3%) | (2,1 12,0) no intercept | 0.39 (-1.3 to 2.1) |
Sex | |||||
Female | 295.5 | 286.1 | -3.2% (-6.7% to 0.4%) | (2,1 12,0) no intercept | 0.47 (-2.2 to 3.1) |
Male | 190.3 | 180.4 | -5.2% (-9.4% to -1.0%) | (3,1 12,0) no intercept | 0.29 (-1.0 to 1.5) |
Age | |||||
0 to 9 | 24.8 | 25.6 | 3.0% (-11.2 to 18.2%) | (3,1 12,0) no intercept | 0.18 (-0.20 to 0.60) |
10 to 14 | 67.2 | 65.1 | -3.1% (-14.3% to 8.7%) | (2,1 12,0) no intercept | -0.21 (-1.6 to 1.2) |
15 to 19 | 326.2 | 299.9 | -8.0% (-13.0% to -3.0%) | (2,1 12,0) no intercept | 0.61 (-2.5 to 3.7) |
20 to 24 | 675.9 | 655.8 | -3.0% (-6.4% to 0.5%) | (2,1 12,0) no intercept | 0.98 (-3.9 to 5.9) |
Income quintile | |||||
Quintile 1 (lowest) | 257.6 | 246.2 | -4.4% (-10.2% to 1.6%) | (0,1 12,1) no intercept | 0.31 (-1.2 to 1.8) |
Quintile 2 | 258.2 | 241.5 | -6.4% (-12.3% to -0.4%) | (2,1 12,0) no intercept | -0.02 (-2.5 to 2.5) |
Quintile 3 | 231.6 | 220.0 | -5.0% (-11.0% to 1.2%) | (3, 1 12,0) no intercept | -0.64 (-2.3 to 0.99) |
Quintile 4 | 229.1 | 218.6 | -4.6% (-10.5% to 1.5%) | (2,1 12,0) no intercept | 0.61 (-2.5 to 3.7) |
Quintile 5 (highest) | 236.4 | 237.2 | 0.4% (-5.7 to 6.6%) | (2,1 12,0) no intercept | 1.5 (-1.3 to 4.3) |
Rural versus urban residence | |||||
Rural | 229.6 | 233.1 | 1.5% (-7.6 to 11.1%) | (0,1 12,3) no intercept | -0.24 (-2.3 to 2.8) |
Urban | 243.4 | 232.4 | -4.6% (-7.4% to -1.7%) | (2,1 12,0) no intercept | 0.23 (-1.5 to 1.9) |